Study number 781343
Your Time Matters & We Value It!
Dates
Apr 16 2026-May 15 2026
Location
Daytona Beach, Florida
Age
24-60
Gender
Male OR Female
Smoker
No
Compensation
$11,401
Group
Part 1 Group 1
Study Details
This is a research study for an investigational drug being developed for the treatment of patients with heart failure with preserved ejection fraction, chronic kidney disease in type 2 diabetes mellitus, and atherosclerotic cardiovascular disease.
Daytona Beach, FL is currently recruiting Healthy Adults, ages 24-60.
Refer a friend & receive $350 per qualified referral
Women Eligibility Criteria
- Women can be of childbearing potential
Body Mass Index
- Participants must have a BMI of:
- 18-32
Smoking criteria
- Smoking is not allowed.
Screening procedures
- Screening procedures for this study may include:
- Vitals
- Physical examination
- Electrocardiogram (ECG)
- Collection of blood samples
- Drug and Alcohol testing
Additional Details
Call Now to Schedule Your Screening Appointment!
Part 1 Cohort 1:
Check-in: Apr 16
Check-out: May 2
Follow up visit: May 15